WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 206042A
Description: AZD9291-DA is a des acryl analogue of AZD9291, which is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors. AZD9291 is highly active in preclinical models and is well tolerated in animal models. It inhibits both activating and resistant EGFR mutations while sparing the normal form of EGFR that is present in normal skin and gut cells, thereby reducing the side effects encountered with currently available medicines.
MedKoo Cat#: 206042A
Name: AZD9291DA HCl salt
Chemical Formula: C25H31N7O
Exact Mass: 445.25901
Molecular Weight: 445.56
Elemental Analysis: C, 67.39; H, 7.01; N, 22.01; O, 3.59
Synonym: AZD9291DA HCl salt; AZD9291 DA; AZD9291-DA; AZD9291-DA hydrochloride
IUPAC/Chemical Name: N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine hydrochloride
InChi Key: HTNTZPBKKCORTP-UHFFFAOYSA-N
InChi Code: InChI=1S/C25H31N7O/c1-30(2)12-13-31(3)23-15-24(33-5)21(14-19(23)26)29-25-27-11-10-20(28-25)18-16-32(4)22-9-7-6-8-17(18)22/h6-11,14-16H,12-13,26H2,1-5H3,(H,27,28,29)
SMILES Code: NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C
1: Targeting resistance in lung cancer. Cancer Discov. 2013 Dec;3(12):OF9. doi: 10.1158/2159-8290.CD-ND2013-025. Epub 2013 Nov 7. PubMed PMID: 24327718.